The coronavirus pandemic has catapulted us all into a future we never imagined or wanted to believe was possible. Beyond the devastating impact that this virus has had on society, with many lives lost, it has kick-started the worst recession in 300 years, disrupted our education system and wreaked havoc on the way we live, work and interact with one another.
Europe's Largest Pharma Job Board, PharmiWeb.jobs works with some of the world's largest pharmaceutical companies, as well as clinical research organisations (CROs), biotech companies and companies within the healthcare sector and Life Sciences generally:
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the issue of patient diversity in research, particularly in light of the Covid-19 outbreak.
Chiesi, an international research-focussed pharmaceutical group (Chiesi Group), has been awarded the exclusive Top Employers UK and the Top Employers Europe for the eighth consecutive year running following an extensive review process by the Top Employers Institute
Quell Therapeutics, a biotechnology company focused on developing engineered T regulatory (Treg) cell therapies, announces that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.
The UK’s life-sciences sector, worth more than £70bn to the country’s economy, is one of the most productive in the world. The sector is innovative but also highly competitive, meaning that marketing communication strategies must be executed precisely for products to succeed.
Healthcare marketing communications agency, Onyx Health and digital product design and build specialists, NE6, have announced a strategic partnership to expand their digital offering to the global pharmaceutical and medical device/technology industry.
Wideblue, a Glasgow-based product design and development consultancy has won a gold award in the European Product Design Awards for a breakthrough medical device developed for its client Cambridge Respiratory Innovation Ltd (CRiL).
Oxford, UK, 13th August 2019 - e-therapeutics plc (AIM: ETX, "e-therapeutics") is pleased to announce an agreement to work with a global, top five pharmaceutical company, on a project in a specific area of biology associated with neurodegenerative diseases.